Skip to main content
. 2024 Aug 5;11(3):521–527. doi: 10.1007/s40801-024-00443-0

Table 2.

Pulmonary function test at baseline, 24 weeks and difference between 0 and 24 weeks

All (n = 94) Discontinued group (n = 41) Continued group (n = 53) p-value
FVC, % of predicted value, baseline 69.2 ± 19.9 69.3 ± 17.3 69.2 ± (15.1) 0.9893
Category, n (%)
 < 70% 46 (48.9) 22 (53.7) 25 (47.2) 0.5327
 ≥ 70% 48 (51.1) 19 (46.3) 28 (52.8)
 < 50% 9 (9.6) 5 (12.2) 4 (7.5) 0.4476
 ≥ 50% 85 (90.4) 36 (87.8) 49 (92.5)
 < 50% 9 (9.6) 5 (12.2) 4 (7.6) 0.4725
 ≥ 50% and < 80% 64 (68.1) 29 (70.7) 35 (66.0)
 ≥ 80% 21 (22.3) 7 (17.1) 14 (26.4)
FVC, % of predicted value, at 24 weeks 66.7 ± 16.3 65.4 ± 14.9 67.5 ± 17.0 0.6539
Change FVC between 0 and 24 weeks − 1.7 ± 8.6 − 1.3 ± 1.5 − 0.1 ± 1.0 0.5076
FEV1,% of predicted value, at baseline 76.1 ± 17.1 78.3 ± 18.0 74.5 ± 16.3 0.2900
FEV1,% of predicted value, at 24 weeks 73.4 ± 17.8 74.5 ± 16.7 73.0 ± 18.4 0.7824
DLco, % of predicted value, at baseline 48.0 ± 15.5 51.3 ± 14.4 46.0 ± 15.9 0.1711
DLco, % of predicted value, at 24 weeks 44.3 ± 15.9 42.0 ± 32.1 45.1 ± 39.0 0.5866
Change DLco between 0 and 24 weeks − 0.7 ± 9.2 − 4.0 ± 6.4 0.47 ± 9.8 0.1724

Values are displayed as number (%), mean ± standard deviation

DLco diffusion capacity of carbon monoxide, FEV1 forced expiratory volume in one second, FVC forced vital capacity